In Silico Study of Desmosdumotin as an Anticancer Agent: Homology Modeling, Docking and Molecular Dynamics Simulation Approach

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 10, 2013-12 ,pp. : 1636-1644

Bentham Science Publishers

Access to resources Recommend Favorite

Ribonucleotide reductase M2 is a promising molecular target for the treatment of oral squamous cell carcinoma

By Iwamoto Kazuki   Nakashiro Koh-Ichi   Tanaka Hiroshi   Tokuzen Norihiko   Hamakawa Hiroyuki  

International Journal of Oncology, Vol. 46, Iss. 5, 2015-05 ,pp. : 1971-1977

Spandidos Publications

Access to resources Recommend Favorite

Ribonucleotide Reductase Inhibition in the Treatment of Advanced Prostate Cancer: an Experimental Approach with Hydroxyurea and Gallium Nitrate in 20 Patients

By Santarossa S.   Vaccher E.   Lenardon O.   Merlo A.   Errante D.   Tirelli U.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1718-1718

Elsevier

Access to resources Recommend Favorite

Molecular docking to explore the possible binding mode of potential inhibitors of thioredoxin glutathione reductase

By        

Molecular Medicine Reports, Vol. 12, Iss. 4, 2015-01 ,pp. : 5787-5795

Spandidos Publications

Access to resources Recommend Favorite

The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer

By          

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1671-1677

Spandidos Publications

Access to resources Recommend Favorite